<?xml version='1.0' encoding='utf8' standalone='yes'?>
<collection><document><id>7033263</id><passage><infon key="name_3">surname:Hu;given-names:Lijuan</infon><infon key="name_2">surname:Ye;given-names:Ling</infon><infon key="name_1">surname:Jiang;given-names:Jinjun</infon><infon key="article-id_pmid">32078069</infon><infon key="name_0">surname:She;given-names:Jun</infon><infon key="year">2020</infon><infon key="article-id_pmc">7033263</infon><infon key="article-id_publisher-id">271</infon><infon key="article-id_doi">10.1186/s40169-020-00271-z</infon><infon key="title">Keywords</infon><infon key="type">front</infon><infon key="elocation-id">19</infon><infon key="volume">9</infon><infon key="license">Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.</infon><infon key="section_type">TITLE</infon><infon key="journal">Clin Transl Med. 2020 Feb 20;9(1):19. doi: 10.1186/s40169-020-00271-z.</infon><infon key="kwd">2019-nCoV Transmission Isolation Respiratory and eye protection Hand hygiene</infon><infon key="name_6">surname:She;given-names:Jun</infon><infon key="name_5">surname:Song;given-names:Yuanlin</infon><infon key="name_4">surname:Bai;given-names:Chunxue</infon><infon key="authors">She J, Jiang J, Ye L, Hu L, Bai C, Song Y</infon><offset>0</offset><text>2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>95</offset><text>An ongoing outbreak of 2019-nCoV pneumonia was first identified in Wuhan, Hubei province, China at the end of 2019. With the spread of the new coronavirus accelerating, person-to-person transmission in family homes or hospitals, and intercity spread of 2019-nCoV occurred. At least 40,261 cases confirmed, 23,589 cases suspected, 909 cases death and 3444 cases cured in China and worldwide 24 countries confirmed 383 cases being diagnosed, 1 case death in February 10th, 2020. At present, the mortality of 2019-nCoV in China is 2.3%, compared with 9.6% of SARS and 34.4% of MERS reported by WHO. It seems the new virus is not as fatal as many people thought. Chinese authorities improved surveillance network, made the laboratory be able to recognize the outbreak within a few weeks and announced the virus genome that provide efficient epidemiological control. More comprehensive information is required to understand 2019-nCoV feature, the epidemiology of origin and spreading, and the clinical phenomina. According to the current status, blocking transmission, isolation, protection, and alternative medication are the urgent management strategies against 2019-nCoV.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1265</offset><text>Background</text></passage><passage><infon key="section_type">FIG</infon><infon key="file">40169_2020_271_Fig1_HTML.jpg</infon><infon key="id">Fig1</infon><infon key="type">fig_caption</infon><offset>1276</offset><text>a The number cases of 2019-nCoV pneumonia confirmed in China by province Feb 10th, 2020; b The number cases of 2019-nCoV pneumonia confirmed in Hubei province, China Feb 10th, 2020</text></passage><passage><infon key="section_type">FIG</infon><infon key="file">40169_2020_271_Fig2_HTML.jpg</infon><infon key="id">Fig2</infon><infon key="type">fig_caption</infon><offset>1457</offset><text>The number of 2019-nCoV pneumonia confirmed in the world 10 Feb 2020</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1526</offset><text>An outbreak of novel coronavirus pneumonia is ongoing, called 2019-nCoV, was first identified in Wuhan, Hubei province, China at the end of 2019. As of February 10th, 2020, at least 40,261 cases confirmed, 23,589 cases suspected, 909 cases death and 3444 cases were cured in China (Fig. 1). 24 countries (Fig. 2) such as Japan, Singapore, Thailand, Korea, and the United States have 383 cases being diagnosed, with 1 case death so far. Although Chinese authorities improved surveillance network, made the laboratory be able to recognize the outbreak within a few weeks and announced the virus genome that provide efficient epidemiological control, World Health Organization (WHO) assessed the risk as 'very high' in China and 'high' in global level in the coming weeks, and declared the public health emergency of international concern (PHEIC) over the global outbreak of 2019-nCoV in January 31, 2020.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2439</offset><text>Based on the current epidemiological survey and data, more comprehensive information is required to understand 2019-nCoV feature, epidemiology of the outbreak including the source, transmission, extent of infection, and the clinical picture. Further strategies are required to determine according to the current status.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>2759</offset><text>Epidemiology</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>2772</offset><text>2019-nCoV features</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2791</offset><text>Coronaviruses are enveloped, positive-sense, single stranded RNA viruses that are distributed broadly among humans, other mammals, and birds, which cause respiratory, enteric, hepatic, and neurologic diseases. Six coronavirus species are known to cause human disease. Four viruses including hCoV-229E, OC43, NL63, and HKU1 are prevalent and typically cause mild respiratory diseases. The two novel fatal coronaviruses emerge periodically in different areas, severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 and Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012. Given the high prevalence and wide distribution of coronaviruses, the genetic diversity and frequent recombination of genomes, and increasing human and animal activities, novel coronaviruses are likely to emerge periodically in humans owing to frequent cross-species infections and occasional spillover events.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3694</offset><text>As Zhu et al. reported that the identified 2019-nCoV genome has been sequenced are phylogenetically the closest to certain beta-coronaviruses detected in bats, belonging to the sarbecovirus subgenus of coronaviridae family, and these results in conjunction with other reports show that it is 75-80% identical to the SARS-CoV and 40% identical to the MERS-CoV. It can be propagated in the same cells for growing SARS-CoV and MERS-CoV. Notably, 2019-nCoV grows better in primary human airway epithelial cells than in standard tissue-culture cells, unlike SARS-CoV or MERS-CoV. It appears that 2019-nCoV uses the same cellular receptor hACE2 (human angiotensin-converting enzyme 2) as SARS-CoV, it seems the transmission may develop after signs of lower respiratory tract disease.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>4474</offset><text>Origin</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4481</offset><text>The origin, spread and virulence of 2019-nCoV remain largely unknown. Most of early infected patients were linked to Huanan seafood wholesale market in Wuhan, China. However,there were 13 of the 41 cases had no link to the marketplace. Most importantly, in the earliest case, the patient became ill on the 1st December 2019 and had no reported access to the seafood market. And no epidemiological link was found between the first patient and later cases. It seems that the seafood market is not the only origin of the virus. The virus probably came into the market place first then it went out of there. Analyses of blood samples in China from people and animals from other animal markets may reveal a clear picture of where the 2019-nCoV originated.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>5232</offset><text>Spreading</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5242</offset><text>An increasing number of cases evidenced the 2019-nCoV have the ability to transmit among humans. To date, no research found the special susceptible population of the new virus seems like SARS, 2019-nCoV is easily transmissible in human generally, but disease severity is not correlated to transmission efficiency. According to the Chinese Center for Disease Control and Prevention (China CDC) reported that laboratory tests ruled out SARS-CoV, MERS-CoV, influenza, avian influenza, adenovirus and other common respiratory pathogens. CDC considered the 2019-nCoV as a possible pathogen causing the outbreak. The 2019-nCoV can cause severe illness in old patients with comorbidities and transmit readily among people. At present, the mortality of 2019-nCoV in China is 2.3%, compared with 9.6% of SARS and 34.4% of MERS reported by WHO. Based on the current data, the new virus is not as fatally as many people thought.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>6160</offset><text>The climate of temperature, relative humidity, and wind velocity should also be attention to the transmission. 2019-nCoV pneumonia emerging attacks in the cold seasonal nature akin to viruses such as SARS and influenza.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>6380</offset><text>Clinical features</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>6398</offset><text>Based on the current epidemiological survey, most individuals had a history of close contact to a patient who had 2019-nCoV infection or a history of travel from Wuhan City or Hubei province, China. The incubation period is generally 3-7 days (within 14 days).</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>6663</offset><text>Symptoms</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>6672</offset><text>The symptoms of 2019-nCoV infection were nonspecific. The most common symptoms were onset of fever, generalized weakness and dry cough. Some patients had headache and/or myalgia, but upper respiratory symptoms such as runny nose were rare. Diarrhea was often identified, which had been reported 10.6% in SARS and up to 30% in MERS. More than half of patients developed shortness of breath, the median duration from disease onset to dyspnea was 8 days. Patients infected with 2019-nCoV might develop acute respiratory distress syndrome (ARDS), followed by septic shock, refractory metabolic acidosis and coagulation dysfunction, if the disease could not be controlled.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>7341</offset><text>Notably, some patients were afebrile or confirmed biologically to have an asymptomatic infection. These cryptic cases of walking pneumonia might serve as a possible source to propagate the outbreak. Further studies on the epidemiological significance of these asymptomatic cases are warranted.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>7635</offset><text>Laboratory findings</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>7655</offset><text>The blood cell counts of patients showed total white blood cells, lymphocyte, and platelet were lower than the average with extended activated thromboplastin time, increased C-reactive protein and muscle enzyme level. D-dimer level were higher and lymphocyte decrease progressively, if the disease had aggravation. The cytokine storm such as IL1B, IL1RA, IL7, IL8 could be associated with disease severity.</text></passage><passage><infon key="section_type">FIG</infon><infon key="file">40169_2020_271_Fig3_HTML.jpg</infon><infon key="id">Fig3</infon><infon key="type">fig_caption</infon><offset>8062</offset><text>The multifocal ground glass changes on chest CT scan were typical of viral pneumonia in one infected 2019-nCoV patients. a shadow in right upper lobe; b shadow in bilateral lobe; c shadow in left lower lobe</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>8269</offset><text>The multifocal ground glass changes on chest CT scan were typical of viral pneumonia [Fig. 3]. If the disease continued to develop, the bilateral multiple lobular and subsegmental areas of consolidation would be found on chest CT scan. The lungs of aged patients showed more diffuse and extensive imaging than those of the younger patients.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>8611</offset><text>Microbiological testing</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>8635</offset><text>Nasopharyngeal swab or sputum samples of patients were available for testing by specific RT-PCR assays for 2019-nCoV to detect the highly conserved RdRp and variable S gene. The cycle threshold values of the sputum samples were 8-13 cycles earlier than those of throat swabs, indicating higher viral loads detected in the lower respiratory tract. It is consistent with the observations in patients with MERS who had higher viral loads in lower respiratory tract samples than in upper respiratory tract samples.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>9148</offset><text>Serum samples for 2019-nCoV which might indicate some virus spillover from the more severely infected lung into the systemic circulation, as previously reported in patients with SARS. However, the first case of 2019-nCoV in the United States report the stool and respiratory specimens from the patients tested positive by RT-PCR for 2019-nCoV, whereas the serum remained negative.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>9529</offset><text>Importantly, the ground glass changes on chest CT scan appeared earlier than the positive for RT-PCR test in some cases. Repeat testing of nasopharyngeal swab or sputum samples are recommended in clinical suspected cases with an initially negative result.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>9785</offset><text>Management strategy</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>9805</offset><text>Blocking transmission</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>9827</offset><text>Learning from the SARS outbreak, which started as animal-to-human transmission during the first phase of the epidemic, all game meat trades should be terminate to prevent this portal of transmission. At the same time, we could not ignore the environmental assessments at the seafood market and investigations to identify the pathogen causing the outbreak.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>10183</offset><text>Person-to-person transmission was efficient and super-spreading events had led to major outbreaks in public gathering places. The severity of disease is an important indirect factor helps to identify those who had been infected. If infection does not cause serious disease or asymptomatic infection, infected people probably end up in health care centers. Instead, they would go to work and travel, thereby potentially spreading the virus to their contacts. Recent epidemiological survey and studies showed the patients who did not travel to Wuhan became infected with the virus after several days of contact with the family members. None of the family members had contacts with Wuhan markets or animals, neither had visited a Wuhan hospital. Person-to-person transmission in family homes or hospital, and intercity spread of 2019-nCoV are occurring, and therefore vigilant control measures are warranted at the whole stage of the epidemic.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>11124</offset><text>Isolation</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>11134</offset><text>Fortunately, with the spread of the new coronavirus accelerating, Chinese authorities responded not only treating the patients and isolating new cases as identified, tracing the contact, but also extended travel restrictions to 48 million people in hardest-hit Hubei province, banned inter-province buses to Beijing and canceled tour group travel abroad. However it is not completely under control, people with symptoms of pneumonia reported travel history to Wuhan have been identified at international airports over the past week.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>11667</offset><text>It is crucial to isolate patients, trace and quarantine contacts as early as possible because asymptomatic infection began to appear. Most importantly, the extent of interhuman transmission needs to be determined. Transmission of SARS-CoV and MERS-CoV occurred to a large extent by means of superspreading events. Superspreading events have been implicated in 2019-nCoV transmission, so educate the public on both food and personal hygiene, and compliance to infection isolation to prevent super-spreading events deserves highly attention.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>12207</offset><text>Protection</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>12218</offset><text>Transmission of 2019-nCoV probably occurs through spreading airborne and contact. Aerosol and fecal-oral transmission remain unclear. Public health measures, including quarantining in the community as well as timely diagnosis and strict adherence to universal precautions in health care settings, were critical in reducing the transmission of 2019-nCoV.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>12574</offset><text>For healthcare personnel, to minimize the chance of exposures to 2019-nCoV needs to follow the standard of contact and airborne precautions, personal protection including gloves, gowns, respiratory protection, eye protection, and hand hygiene. Some procedures performed on 2019-nCoV infected patients could generate infectious aerosols, e.g., nasopharyngeal specimen collection, sputum induction, and open suctioning of airways should be performed cautiously. If performed, these procedures should take place in an airborne infection isolation room, and personnel should use respiratory and eye protection, and hand hygiene. In addition, management of environmental infection control including laundry, food service utensils, and medical waste should also be performed. Artificial Intelligence (AI), alternative selection to reducing infection for medical personnel, should be explored (Joint developed by Respiratory Research Institution of Zhongshan Hospital, Fudan University and RealMax Ltd Co), which will be benefit for remote guidance of practices.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>13630</offset><text>Alternative medication</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>13653</offset><text>No antiviral treatment for coronavirus infection has been proven to be effective. Previous studies showed the combination of lopinavir and ritonavir may be beneficial for SARS-CoV and MERS-CoV infected patients. Treatment with intravenous remdesivir (a novel nucleotide analogue prodrug in development) showed significant improvement for the first case in US. A trial has been initiated quickly to assess the efficacy and safety of remdesivir in patients hospitalized with 2019-nCoV infection. Recently, a potent binding of 2019-nCoV spike protein by a SARS-CoV specific human monoclonal antibody were under investigation.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>14276</offset><text>As the cytokine storm was observed in severe 2019-nCoV infection patients, low dose corticosteroids has been used to treat the patients for possible benefit by reducing inflammatory-induced lung injury. However, corticosteroids did not reduce the mortality for SARS-CoV and MERS-CoV infection by WHO interim guidance.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>14594</offset><text>Treatment regiments were classified into three categories depends on the severity of the disease: (1) For mild to moderate disease, the major treatment is supportive therapy; (2) for severe disease, oxygen inhalation through mask, high nasal oxygen flow inhalation, or non-invasive ventilation is needed. Careful and dynamic evaluation of patients oximeter and Chest imaging as well as laboratory examination is important; (3) for very severe disease, protective mechanical ventilation after tracheal intubation is required, and prone position ventilation followed if P/F ratio not improved, and eventually extracorporeal membrane oxygenation (ECMO) might be implemented if prone position plus mechanical ventilation did not work. Notably, the anxiety and depression of patients need to be consideration. We should not only pay attention to disease treatment, but also the mental issues of patients.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>15494</offset><text>In addition, some traditional Chinese medicine (TCM), such as Snow Lotus (Saussuea involucrata), LianHuaQingWen, LiuShenWan might be beneficial for coronavirus infection treatment through immunity enhancement. Further evidence is needed to assess the effect of TCM treatment for patients infected with 2019-nCoV.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>15807</offset><text>Conclusions</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>15819</offset><text>2019-nCoV pneumonia are emerging attack at China and worldwide in the winter of 2019-2020. The identified 2019-nCoV genome has been sequenced the closest to some beta-coronaviruses detected in bats. Person-to-person transmission in family homes or hospital, and intercity spread of 2019-nCoV are occurring. At present, the mortality of 2019-nCoV in China is 2.3%, compared with 9.6% of SARS and 34.4% of MERS reported by WHO. It seems the new virus is not as fatally as many people thought. The most common symptoms were onset of fever, generalized weakness and dry cough. Notably, some patients were afebrile or confirmed biologically to have an asymptomatic infection. And the ground glass changes on chest CT scan were earlier than the positive for RT-PCR test in some cases. Repeat testing of nasopharyngeal swab or sputum samples are recommended in clinical suspected cases with an initially negative result. According to the current status, blocking transmission, isolation, respiratory and eye protection, and hand hygiene are the urgent management strategies against 2019-nCoV. </text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">title</infon><offset>16906</offset><text>Abbreviations</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>16920</offset><text>WHO</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>16924</offset><text>World Health Organization</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>16950</offset><text>PHEIC</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>16956</offset><text>Public health emergency of international concern</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17005</offset><text>SARS</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17010</offset><text>Severe acute respiratory syndrome</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17044</offset><text>MERS</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17049</offset><text>Middle East respiratory syndrome</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17082</offset><text>China CDC</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17092</offset><text>Chinese Center for Disease Control and Prevention</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17142</offset><text>ARDS</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17147</offset><text>Acute respiratory distress syndrome</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17183</offset><text>AI</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17186</offset><text>Artificial Intelligence</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17210</offset><text>ECMO</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17215</offset><text>Extracorporeal membrane oxygenation</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17251</offset><text>TCM</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17255</offset><text>Traditional Chinese medicine</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">footnote</infon><offset>17284</offset><text>Publisher's Note</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">footnote</infon><offset>17301</offset><text>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title</infon><offset>17420</offset><text>Authors' contributions</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>17445</offset><text>Study concept and design (YS), data acquisition and interpretation (JS, JJ, LY and LH), drafting (JS), revision (YS and CB). All authors read and approved the final manuscript.</text></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">title</infon><offset>17622</offset><text>Funding</text></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">paragraph</infon><offset>17630</offset><text>This work was sponsored by Shanghai Municipal Key Clinical Specialty (shslczdzd02201); Shanghai Top-Priority Clinical Key Disciplines Construction Project (2017ZZ02013). SJ was sponsored by Shanghai Pujiang Program (16PJD012).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title</infon><offset>17857</offset><text>Availability of data and materials</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>17892</offset><text>Not applicable.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title</infon><offset>17908</offset><text>Ethics approval and consent to participate</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>17951</offset><text>Not applicable.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title</infon><offset>17967</offset><text>Consent for publication</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>17991</offset><text>Not applicable.</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title</infon><offset>18007</offset><text>Competing interests</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>18027</offset><text>All authors declare that they have no conflicts of interests.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>18089</offset><text>References</text></passage><passage><infon key="name_2">surname:Wang;given-names:WL</infon><infon key="name_1">surname:Zhang;given-names:DY</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Zhu;given-names:N</infon><infon key="pub-id_doi">10.1056/nejmoa2001017</infon><infon key="year">2020</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><offset>18100</offset><text>A novel coronavirus from patients with pneumonia in China, 2019</text></passage><passage><infon key="name_2">surname:Li;given-names:XW</infon><infon key="name_1">surname:Wang;given-names:YM</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Huang;given-names:CL</infon><infon key="pub-id_doi">10.1016/s0140-6736(20)30183-5</infon><infon key="year">2020</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><offset>18164</offset><text>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>18247</offset><text>New features of novel coronavirus (2019-nCoV) pneumonia. https://new.qq.com/omn/20200128/20200128A07H4S00.html. Accessed 30 Jan 2020</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>18380</offset><text>Novel coronavirus (2019-nCoV) situation Report-7 http://www.who.int/docs/default-source/coronavirus/situation-report/20200127-sitrep-7-2019-ncov.pdf?sfvrsn=98ef79f5_2. Accessed 27 Jan 2020)</text></passage><passage><infon key="volume">81</infon><infon key="name_1">surname:Leibowitz;given-names:JL</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Weiss;given-names:SR</infon><infon key="fpage">85164</infon><infon key="year">2011</infon><infon key="source">Adv Virus Res</infon><infon key="type">ref</infon><offset>18572</offset><text>Coronavirus pathogenesis</text></passage><passage><infon key="volume">24</infon><infon key="name_2">surname:Shi;given-names:W</infon><infon key="name_1">surname:Wong;given-names:G</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Su;given-names:S</infon><infon key="fpage">490</infon><infon key="pub-id_doi">10.1016/j.tim.2016.03.003</infon><infon key="pub-id_pmid">27012512</infon><infon key="year">2016</infon><infon key="source">Trends Microbiol</infon><infon key="type">ref</infon><infon key="lpage">502</infon><offset>18597</offset><text>Epidemiology, genetic recombination, and pathogenesis of coronaviruses</text></passage><passage><infon key="volume">17</infon><infon key="name_2">surname:Shi;given-names:ZL</infon><infon key="name_1">surname:Li;given-names:F</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Cui;given-names:J</infon><infon key="fpage">181</infon><infon key="pub-id_doi">10.1038/s41579-018-0118-9</infon><infon key="pub-id_pmid">30531947</infon><infon key="year">2019</infon><infon key="source">Nat Rev Microbiol</infon><infon key="type">ref</infon><infon key="lpage">192</infon><offset>18668</offset><text>Origin and evolution of pathogenic coronaviruses</text></passage><passage><infon key="name_3">surname:Zhou;given-names:B</infon><infon key="name_2">surname:Liu;given-names:Y</infon><infon key="name_1">surname:Liu;given-names:W</infon><infon key="name_0">surname:Wong;given-names:G</infon><infon key="fpage">398</infon><infon key="pub-id_doi">10.1016/j.chom.2015.09.013</infon><infon key="pub-id_pmid">26468744</infon><infon key="year">2015</infon><infon key="source">Cell Host Microbe</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="section_type">REF</infon><infon key="lpage">401</infon><infon key="name_5">surname:Gao;given-names:GF</infon><infon key="name_4">surname:Bi;given-names:Y</infon><offset>18717</offset><text>MERS, SARS, and Ebola: the role of super-spreaders in infectious disease</text></passage><passage><infon key="section_type">REF</infon><infon key="name_0">surname:Perlman;given-names:S</infon><infon key="pub-id_doi">10.1056/nejme2001126</infon><infon key="year">2020</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><offset>18790</offset><text>Another decade, another coronavirus</text></passage><passage><infon key="name_2">surname:Li;given-names:J</infon><infon key="name_1">surname:Zhao;given-names:X</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Lu;given-names:RJ</infon><infon key="pub-id_doi">10.1016/s0140-6736(20)30251-8</infon><infon key="year">2020</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><offset>18826</offset><text>Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding</text></passage><passage><infon key="name_2">surname:Wang;given-names:XG</infon><infon key="name_1">surname:Yang;given-names:XL</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Zhou;given-names:P</infon><infon key="pub-id_doi">10.1101/2020.01.22.914952</infon><infon key="year">2020</infon><infon key="source">BioRxiv</infon><infon key="type">ref</infon><offset>18947</offset><text>Discovery of a novel coronavirus associated with the recent pneumonia outbreak in 2 humans and its potential bat origin</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>19067</offset><text>Cohen J. Wuhan seafood market may not be source of novel virus spreading globally.https://www.sciencemag.org/news/2020/01/wuhan-seafood-market-may-not-be-source-novel-virus-spreading-globally. Accessed 30 Jan 2020</text></passage><passage><infon key="name_2">surname:Wu;given-names:P</infon><infon key="name_1">surname:Guan;given-names:XH</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Li;given-names:Q</infon><infon key="pub-id_doi">10.1056/nejmoa2001316</infon><infon key="year">2020</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><offset>19281</offset><text>Early transmission dynamics in Wuhan, China, of novel coronavirus infected pneumonia</text></passage><passage><infon key="name_2">surname:Luong;given-names:QC</infon><infon key="name_1">surname:Nguyen;given-names:TV</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Phan;given-names:LT</infon><infon key="pub-id_doi">10.1056/nejmoa2001272</infon><infon key="year">2020</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><offset>19366</offset><text>Importation and human-to-human transmission of a novel coronavirus in Vietnam</text></passage><passage><infon key="volume">35</infon><infon key="name_2">surname:Song;given-names:MS</infon><infon key="name_1">surname:Zeng;given-names:X</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Xiong;given-names:P</infon><infon key="fpage">69</infon><infon key="pub-id_doi">10.1111/j.1744-313X.2007.00741.x</infon><infon key="pub-id_pmid">18186801</infon><infon key="year">2008</infon><infon key="source">Int J Immunogenet</infon><infon key="type">ref</infon><infon key="lpage">74</infon><offset>19444</offset><text>Lack of association between HLA-A, -B and -DRB1 alleles and the development of SARS: a cohort of 95 SARS-recovered individuals in a population of Guangdong, southern China</text></passage><passage><infon key="name_2">surname:van Doremalen;given-names:N</infon><infon key="name_1">surname:Marion;given-names:K</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Vincent;given-names:JM</infon><infon key="pub-id_doi">10.1056/nejmp2000929</infon><infon key="year">2020</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><offset>19616</offset><text>A novel coronavirus emerging in China:key questions for impact assessment</text></passage><passage><infon key="name_2">surname:Dong;given-names:X</infon><infon key="name_1">surname:Zhou;given-names:M</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Chen;given-names:NS</infon><infon key="pub-id_doi">10.1016/s0140-6736(20)30211-7</infon><infon key="pub-id_pmid">32066541</infon><infon key="year">2020</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><offset>19692</offset><text>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>19822</offset><text>WHO statement regarding cluster of pneumonia cases in Wuhan, China. https://www.who.int/china/news/detail/09-01-2020-who-statement-regarding-cluster-of-pneumonia-cases-in-wuhan-china. Accessed 27 Jan 2020</text></passage><passage><infon key="volume">34</infon><infon key="name_2">surname:Lan;given-names:W</infon><infon key="name_1">surname:Yun;given-names:HM</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Yuan;given-names:JS</infon><infon key="fpage">234</infon><infon key="pub-id_doi">10.1016/j.ajic.2005.12.006</infon><infon key="year">2005</infon><infon key="source">China Am J Infect Control</infon><infon key="type">ref</infon><infon key="lpage">236</infon><offset>20027</offset><text>A climatologic investigation of the SARS-CoV outbreak in Beijing</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>20092</offset><text>National Health Commission of the People's Republic of China. Diagnosis and treatment of new coronavirus pneumonia (version 5) http://www.nhc.gov.cn/. Accessed 30 Jan 2020</text></passage><passage><infon key="name_2">surname:Kok;given-names:KH</infon><infon key="name_1">surname:Yuan;given-names:SF</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Chan Jasper;given-names:FW</infon><infon key="pub-id_doi">10.1016/s0140-6736(20)30154-9</infon><infon key="year">2020</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><offset>20266</offset><text>A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster</text></passage><passage><infon key="volume">210</infon><infon key="name_2">surname:Makhdoom;given-names:HQ</infon><infon key="name_1">surname:Al-Tawfiq;given-names:JA</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Memish;given-names:ZA</infon><infon key="fpage">1590</infon><infon key="pub-id_doi">10.1093/infdis/jiu292</infon><infon key="pub-id_pmid">24837403</infon><infon key="year">2014</infon><infon key="source">J Infect Dis</infon><infon key="type">ref</infon><infon key="lpage">1594</infon><offset>20411</offset><text>Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome</text></passage><passage><infon key="volume">10</infon><infon key="name_2">surname:Wu;given-names:AK</infon><infon key="name_1">surname:Cheng;given-names:VC</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Hung;given-names:IF</infon><infon key="fpage">1550</infon><infon key="pub-id_doi">10.3201/eid1009.040058</infon><infon key="pub-id_pmid">15498155</infon><infon key="year">2004</infon><infon key="source">Emerg Infect Dis</infon><infon key="type">ref</infon><infon key="lpage">1557</infon><offset>20526</offset><text>Viral loads in clinical specimens and SARS manifestations</text></passage><passage><infon key="name_2">surname:Lindquis;given-names:S</infon><infon key="name_1">surname:DeBolt;given-names:C</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Holshue;given-names:ML</infon><infon key="pub-id_doi">10.1056/nejmoa2001191</infon><infon key="year">2020</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><offset>20584</offset><text>First case of 2019 novel coronavirus in the United States</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>20642</offset><text>The Washington Post https://www.washingtonpost.com/health/chinese-leader-warns-of-accelerating-spread-of-deadly-coronavirus/2020/01/25/6409bc78-3f8c-11ea-baca-eb7ace0a3455_story.html. Accessed 25 Jan 2020</text></passage><passage><infon key="name_2">surname:Hayden;given-names:FG</infon><infon key="name_1">surname:Horby;given-names:PE</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Wang;given-names:C</infon><infon key="pub-id_doi">10.1016/s0140-6736(20)30182-9</infon><infon key="year">2020</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><offset>20847</offset><text>A novel coronavirus outbreak of global health concern</text></passage><passage><infon key="name_3">surname:Memish;given-names:ZA</infon><infon key="name_2">surname:Kim;given-names:YJ</infon><infon key="name_1">surname:Azhar;given-names:EI</infon><infon key="name_0">surname:Hui;given-names:DS</infon><infon key="fpage">e217</infon><infon key="pub-id_doi">10.1016/S1473-3099(18)30127-0</infon><infon key="pub-id_pmid">29680581</infon><infon key="year">2018</infon><infon key="source">Lancet Infect Dis</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="section_type">REF</infon><infon key="lpage">e227</infon><infon key="name_5">surname:Zumla;given-names:A</infon><infon key="name_4">surname:Oh;given-names:MD</infon><offset>20901</offset><text>Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission</text></passage><passage><infon key="name_2">surname:Yuen;given-names:KY</infon><infon key="name_1">surname:Guan;given-names:Y</infon><infon key="name_0">surname:Peiris;given-names:JS</infon><infon key="fpage">S88</infon><infon key="issue">Suppl</infon><infon key="pub-id_doi">10.1038/nm1143</infon><infon key="pub-id_pmid">15577937</infon><infon key="year">2004</infon><infon key="source">Nat Med</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="section_type">REF</infon><infon key="lpage">S97</infon><offset>21028</offset><text>Severe acute respiratory syndrome</text></passage><passage><infon key="name_2">surname:Cao;given-names:B</infon><infon key="name_1">surname:Cruz;given-names:CSD</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Carlos;given-names:WG</infon><infon key="pub-id_doi">10.1164/rccm.2014p7</infon><infon key="year">2020</infon><infon key="source">Am J Respir Crit Care Med</infon><infon key="type">ref</infon><offset>21062</offset><text>Novel Wuhan (2019-nCoV) Coronavirus</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>21098</offset><text>Interim infection prevention and control recommendations for patients with known or patients under investigation for 2019 novel coronavirus (2019-nCoV) in a healthcare setting. https://www.cdc.gov/coronavirus/2019-nCoV/hcp/infection-control.html. Accessed 30 Jan 2020</text></passage><passage><infon key="volume">59</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Chu;given-names:CM</infon><infon key="fpage">252</infon><infon key="pub-id_doi">10.1136/thorax.2003.012658</infon><infon key="pub-id_pmid">14985565</infon><infon key="year">2004</infon><infon key="source">Thorax</infon><infon key="type">ref</infon><infon key="lpage">256</infon><offset>21366</offset><text>Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings</text></passage><passage><infon key="volume">19</infon><infon key="name_2">surname:Balkhy;given-names:HH</infon><infon key="name_1">surname:Alothman;given-names:A</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Arabi;given-names:YM</infon><infon key="fpage">81</infon><infon key="pub-id_doi">10.1186/s13063-017-2427-0</infon><infon key="pub-id_pmid">29382391</infon><infon key="year">2018</infon><infon key="source">Trials</infon><infon key="type">ref</infon><offset>21462</offset><text>Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial</text></passage><passage><infon key="name_2">surname:Huang;given-names:AL</infon><infon key="name_1">surname:Li;given-names:C</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Tian;given-names:XL</infon><infon key="pub-id_doi">10.1101/2020.01.28.923011v1</infon><infon key="year">2019</infon><infon key="source">bioRxiv</infon><infon key="type">ref</infon><offset>21638</offset><text>A potent binding of 2019-nCoV spike protein by a SARS-CoV specific human monoclonal antibody</text></passage><passage><infon key="volume">197</infon><infon key="name_2">surname:Al-Hameed;given-names:F</infon><infon key="name_1">surname:Mandourah;given-names:Y</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Arabi;given-names:YM</infon><infon key="fpage">757</infon><infon key="pub-id_doi">10.1164/rccm.201706-1172OC</infon><infon key="pub-id_pmid">29161116</infon><infon key="year">2018</infon><infon key="source">Am J Respir Crit Care Med</infon><infon key="type">ref</infon><infon key="lpage">767</infon><offset>21731</offset><text>Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>21820</offset><text>WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Jan 11, 2020. https://www.who.int/internal-publications-detail/clinicalmanagement-of-severe-acute-respiratory-infection-when-novelcoronavirus-(ncov)-infection-is-suspected. Accessed 30 Jan 2020</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>22131</offset><text>LianhuaQingwenis is recommended for new coronavirus treatment.http://www.p5w.net/stock/news/gsxw/202001/t20200128_2373523.htm. Accessed 30 Jan 2020</text></passage><passage><infon key="name_3">surname:Yang;given-names:ZF</infon><infon key="name_2">surname:Zhao;given-names:J</infon><infon key="name_1">surname:Huang;given-names:WB</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Ma;given-names:QH</infon><infon key="pub-id_doi">10.1016/j.jep.2020.112584</infon><infon key="year">2020</infon><infon key="source">J Ethnopharmacol</infon><infon key="type">ref</infon><offset>22279</offset><text>Liu Shen Wan inhibits influenza a virus and excessive virus-induced inflammatory response via suppression of TLR4/NF-KB signaling pathway in vitro and in vivo</text></passage></document>
</collection>